Abstract
Objective
To characterize the motivations and attitudes of healthy subjects who volunteer for phase I studies as well as their perception of the informed consent procedure and participation in the study.
Methods
Subjects (n = 136, 48.5/51.5% males/females, 26.9 ± 5.5 years; 51.9% students, 42.2% employed, 5.9% unemployed) anonymously answered questionnaires regarding study participation and personality (Revised NEO Personality Inventory).
Results
Financial reward was the most important motivation and was most valued by subjects with a lower monthly income (p < 0.01) and lower education (p < 0.05). Personality traits correlated differently with the various motivators for participation. “Word-of-mouth” (mainly by ex-participants) was the source of information on the phase I study for 94.9% of the participants. Most (88.2%) subjects consulted other people (family member/partner, 53.3% of participants; friends, 40.0%; physician, 25.0%) before deciding to participate. In 80% of the cases, the people consulted recommended that the subject not participate, with the risk of serious complications being the main objection in 75.7% cases. The information provided was generally assessed favorably; 34.6% of subjects considered the discomfort caused by participation to be less than that originally reported during the consent procedure, 58.8% considered it to be identical and 6.6% considered it to be higher. Most of the subjects (81.6%) declared that they never felt at risk of a serious complication during their participation in the study, 16.2% occasionally felt that they were at risk and 2.2% felt that they were at risk for a significant period of time. Personality traits correlated with the decision to ask someone else’s opinion, the manner in which information provided was rated and the perception of the risk taken during participation.
Conclusion
Financial reward as the main motivator for participation in phase I studies was less valued by healthy volunteers with a higher income and education. A subject’s motivations and perceptions toward participation were found to be influenced by individual characteristics, including some personality traits.
Similar content being viewed by others
References
Tishler CL, Bartholomae S (2002) The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives. J Clin Pharmacol 42:365–375
Bigorra J, Baños JE (1990) Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials. Eur J Clin Pharmacol 38:443–446
Esecover H, Malitz S, Wilkens B (1961) Clinical profiles of paid normal subjects volunteering for hallucinogen drug studies. Am J Psychiatry 117:910–915
Hassar M, Pocelinko R, Weintraub M, Nelson D, Thomas G, Lasagna L (1977) Free-living volunteer’s motivations and attitudes toward pharmacologic studies in man. Clin Pharmacol Ther 21:515–519
Martin DC, Arnold JD, Zimmerman TF, Richart RH (1968) Human subjects in clinical research: a report of three studies. N Engl J Med 279:1426–1431
Novak E, Seckman CE, Stewart RD (1977) Motivations for volunteering as research subjects. J Clin Pharmacol 365–371
Van Gelderen CEM, Savelkoul TJF, Van Dokkum W, Meulenbelt J (1993) Motives and perception of healthy volunteers who participate in experiments. Eur J Clin Pharmacol 45:15–21
Vrlovac R, Francetic I, Rotim K (1990) Drug trials on healthy volunteers in Yugoslavia. Int J Clin Pharmacol Ther Toxicol 28:375–379
Costa PT, McCrae RR (1992) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI). Professional manual. Psychological Assessment Resources, Odessa, FL
Digman JM (1990) Emergence of the five factor. Annu Rev Psychol 41:417–440
Goldberg LR (1990) An alternative “Description of Personality”: the big-five factor structure. J Pers Soc Psychol 59:1216–1229
Pedroso-de-Lima M, Simões A (2000) NEO PI-R: Inventário de Personalidade NEO Revisto. Manual profissional. CEGOC–TEA, Ltd, Lisbon
Rocha D (2000) NEO PI-R: CEGOC system, software para cotação informatizada do teste NEO-PI-R. CEGOC-TEA, Lisbon
Anderson JA, Weijer C (2001) The research subject as entrepeneur. Am J Bioethics 1:67–69
Ayd FJ, Calabresi P (1972) Motivations and rewards for volunteering to be an experimental subject. Clin Pharmacol Ther 13:771–781
Dickert N, Grady C (1999) What’s the price of a research subject? Approaches to payment for research participation. N Engl J Med 341:198–203
Erb K, Staks T, Su C-A (1994) Trends in the remuneration of volunteers. Appl Clin Trials 3:54–58
Gribbin K, Schaie KW (1976) Monetary incentive, age, and cognition. Exp Aging Res 2:461–468
Hyun I (2006) Fair payment or undue inducement? Nature 442:629–630
McGee C (1997) A piece of my mind: subject to payment? JAMA 278:199–200
Russel ML, Moralejo DG, Burgess ED (2000) Paying research subjects: participant’s perspectives. J Med Ethics 26:126–130
Tishler CL, Bartholomae S (2003) Repeat participation among normal healthy research volunteers: professional guinea pigs in clinical trials? Perspect Biol Med 46:508–520
Vere DW (1991) Payments to healthy volunteers: ethical problems. Br J Clin Pharmacol 32:141–142
Viens AM (2001) Socio-economic status and inducement to participate. Am J Bioethics 1:69
Weijer C (1999) What’s the price of a research subject? N Engl J Med 341:206
Zink S (2001) Maybe we should pay them more. Am J Bioethics 1:88–89
Almeida L, Azevedo B, Nunes T, Vaz-da-Silva M, Albino-Teixeira A, Falcao A, Coelho R, Soares-da-Silva P (2006) Healthy subjects’ motivations to volunteer for participation in human pharmacology studies (Abstr 1071). J Clin Pharmacol 46:1077
Newton L (1982) Inducement, due and otherwise. IRB 4:4–6
Rabin C, Tabak N (2006) Healthy participants in phase I clinical trials: the quality of their decision to take part. J Clin Nurs 15:971–979
Acknowledgements
We express our deep gratitude to the volunteers for agreeing to participate, and to Grazina Binkauskiene, PhD, and Vitalija Avdejenkova, PhD, for their assistance in the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Almeida, L., Azevedo, B., Nunes, T. et al. Why healthy subjects volunteer for phase I studies and how they perceive their participation?. Eur J Clin Pharmacol 63, 1085–1094 (2007). https://doi.org/10.1007/s00228-007-0368-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-007-0368-3